November 21, 2024

Deuruxolitinib Shows Promise for Alopecia

Deuruxolitinib achieved significant hair regrowth in a Phase 3 clinical trial. 

Conexiant

November 20, 2024

Analysis Identifies New Genetic Loci for Atopic Dermatitis

Conexiant

November 20, 2024

Topical Ruxolitinib Offers Rapid Relief for Atopic Dermatitis

Conexiant

November 19, 2024

Art-Based Training Improves Neurology Observational Skills

Conexiant

November 18, 2024

Renowned Dermatologist Goldsmith Dies at 86

"No one ever trades in a Rolls Royce—they just maintain the one they have," quipped pioneering dermatologist Lowell Goldsmith after cardiac surgery, exemplifying the wit and wisdom that marked his 57-year career advancing dermatologic medicine.

Conexiant

November 05, 2024

CDC Warns of Hard-to-Treat U.S. Ringworm

Highly contagious and hard-to-treat fungal infections, including sexually transmitted ringworm, emerging in the U.S.

Conexiant

November 04, 2024

Upadacitinib Study Shows Sustained Atopic Dermatitis Results

New data from three Phase 3 trials show upadacitinib maintains strong efficacy and safety in adolescent atopic dermatitis, with significant improvements in pruritus and skin clearance.

Conexiant

October 31, 2024

FDA Grants New EB Treatment Designation

Squamous cell carcinoma is the leading cause of mortality in severe epidermolysis bullosa," notes Dr. Robert Kirsner, as FDA grants rare pediatric designation to mitochondrial-targeting therapy.

Conexiant

October 29, 2024

Study: Parent Physicians Face $2M Pay Gap

Parent physicians face stark earning divides: mothers' pay drops with each child while fathers see raises, creating $2M career gap.

Conexiant